ImpediMed IPDQF Stock
ImpediMed Price Chart
ImpediMed IPDQF Financial and Trading Overview
| ImpediMed stock price | 0.0045 USD |
| Previous Close | 0.0045 USD |
| Open | 0.0066 USD |
| Bid | 0.0035 USD x 27950000 |
| Ask | 0.0067 USD x 3000000 |
| Day's Range | 0.0045 - 0.0066 USD |
| 52 Week Range | 0.002 - 0.03 USD |
| Volume | 430K USD |
| Avg. Volume | 26.67K USD |
| Market Cap | 16.48M USD |
| Beta (5Y Monthly) | 1.068 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IPDQF Valuation Measures
| Enterprise Value | 17.79M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.1278465 |
| Price/Book (mrq) | 2.1650956 |
| Enterprise Value/Revenue | 1.217 |
| Enterprise Value/EBITDA | -0.842 |
Trading Information
ImpediMed Stock Price History
| Beta (5Y Monthly) | 1.068 |
| 52-Week Change | -85.00000000000000000000000000000000% |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 0.03 USD |
| 52 Week Low | 0.002 USD |
| 50-Day Moving Average | 0.004424 USD |
| 200-Day Moving Average | 0.01 USD |
IPDQF Share Statistics
| Avg. Volume (3 month) | 26.67K USD |
| Avg. Daily Volume (10-Days) | 59.55K USD |
| Shares Outstanding | 3.66B |
| Float | 3.33B |
| Short Ratio | N/A |
| % Held by Insiders | 9.20% |
| % Held by Institutions | 21.05% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1027:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | -170.44% |
| Operating Margin (ttm) | -146.21% |
| Gross Margin | 87.38% |
| EBITDA Margin | -144.63% |
Management Effectiveness
| Return on Assets (ttm) | -34.78% |
| Return on Equity (ttm) | -162.35% |
Income Statement
| Revenue (ttm) | 14.61M USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | 5.70% |
| Gross Profit (ttm) | 12.77M USD |
| EBITDA | -21135000 USD |
| Net Income Avi to Common (ttm) | -24907000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.29M USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 16.6M USD |
| Total Debt/Equity (mrq) | 162.91 USD |
| Current Ratio (mrq) | 3.81 |
| Book Value Per Share (mrq) | 0.00207843 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17855000 USD |
| Levered Free Cash Flow (ttm) | -14240375 USD |
Profile of ImpediMed
| Country | United States |
| State | CA |
| City | Carlsbad |
| Address | 5900 Pasteur Court |
| ZIP | 92008 |
| Phone | 760 585 2100 |
| Website | https://www.impedimed.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 66 |
ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed for early lymphedema detection; BodyComp Analysis; Segmental BodyComp Analysis; and HF-Dex Analysis for Heart Failure. It also provides Lymphedema Prevention Program; and BodyComp Analysis for survivorship health. The company specializes in cancer survivorship, heart health management, medical weight management, wellness, and research. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California.
Q&A For ImpediMed Stock
What is a current IPDQF stock price?
ImpediMed IPDQF stock price today per share is 0.0045 USD.
How to purchase ImpediMed stock?
You can buy IPDQF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImpediMed?
The stock symbol or ticker of ImpediMed is IPDQF.
Which industry does the ImpediMed company belong to?
The ImpediMed industry is Medical Devices.
How many shares does ImpediMed have in circulation?
The max supply of ImpediMed shares is 3.66B.
What is ImpediMed Price to Earnings Ratio (PE Ratio)?
ImpediMed PE Ratio is now.
What was ImpediMed earnings per share over the trailing 12 months (TTM)?
ImpediMed EPS is -0.01 USD over the trailing 12 months.
Which sector does the ImpediMed company belong to?
The ImpediMed sector is Healthcare.
